Big Data & AI Are Rewriting Pharma R&DAI is no longer simply another tool in pharma. It is changing how drug discovery, clinical trials, safety, and regulatory decision-making operate. Join this workshop for an evidence-based look at what AI has actually delivered, what remains unproven, and how regulators are responding. What You’ll Learn
- How Big Data and AI have changed pharma’s operating assumptions
- Where AI is delivering real results across discovery, trials, and safety
- Which FDA, EMA, and ICH frameworks are binding versus still evolving
- How to evaluate AI tools and claims using a risk-based context-of-use approach
- The key regulatory and compliance developments to watch over the next 12-18 months
- Practical insights followed by Q&A
Register by August 20 and save 20% with Early Bird code SAVE20. *All participants receive a Certificate of Attendance upon completion.
|
No comments:
Post a Comment